Dicer substrate RNA peptide conjugates and methods for RNA therapeutics

Details for Australian Patent Application No. 2007286059 (hide)

Owner Nastech Pharmaceutical Company Inc.

Inventors Quay, Steven C.; Fam, Renata; Johnson, Paul Hickok; Houston Jr, Michael E.; Adami, Roger C.

Agent Shelston IP

Pub. Number AU-A-2007286059

PCT Pub. Number WO2008/022046

Priority 60/945,868 22.06.07 US; 60/822,896 18.08.06 US; 60/939,578 22.05.07 US

Filing date 10 August 2007

Wipo publication date 21 February 2008

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/444 (2006.01)

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/497 (2006.01)

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/022046 Priority application(s): WO2008/022046

10 December 2009 Alteration of Name

  The name of the applicant has been altered to MDRNA, Inc.

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286064-Advanced emergency geographical information system

2007286057-Oxygen activated heater and methods of manufacturing same